Table 2.
Results from Monofractal Detrended Fluctuation Analysis of Sensor Glucose and ISIG Data Over Cohort
| Analyzing calibrated SG data | |||
| CGM device type (both in abdomen) | |||
| Guardian | iPro2 | P value | |
| Number of data sets | 9 | 8 | |
| Scaling exponent (H) | 1.43 (1.37–1.48) | 1.56 (1.46–1.60) | |
| Difference in H (iPro2 - Guardian) | 0.10 (0.03–0.20) | 0.08a | |
| Sensor location (both iPro2) | |||
| Abdomen | Thigh | P value | |
| Number of data sets | 8 | 9 | |
| Scaling exponent (H) | 1.56 (1.46–1.60) | 1.52 (1.50–1.61) | |
| Difference in H (thigh - abdomen) | 0.04 (-0.06–0.11) | 0.64a | |
| Analyzing pre-calibration ISIG data | |||
| CGM device type (both in abdomen) | |||
| Guardian | iPro2 | P value | |
| Number of data sets | 9 | 8 | |
| Scaling exponent (H) | 1.42 (1.34–1.52) | 1.54 (1.37–1.60) | |
| Difference in H (iPro2 - Guardian) | 0.06 (-0.04–0.10) | 0.53a | |
| Sensor location (both iPro2) | |||
| Abdomen | Thigh | P value | |
| Number of data sets | 8 | 9 | |
| Scaling exponent (H) | 1.54 (1.37–1.60) | 1.51 (1.47–1.60) | |
| Difference in H (thigh - abdomen) | 0.04 (-0.03–0.09) | 0.38a | |
Wilcoxon signed rank test.